The global asthma treatment market size is expected to reach USD 26.01 billion by 2027, exhibiting a CAGR of 4.5% during the forecast period. The growing incidence of respiratory diseases such of chronic obstructive pulmonary disease (COPD), chronic bronchitis, emphysema, lung cancer, asthma, and pleural effusion will spur demand for asthma treatment during the forecast period, mentioned in a report
Click here to get the short-term and long-term impact of COVID-19 on this Market.
Please visit: https://www.fortunebusinessinsights.com/industry-reports/asthma-treatment-market-101039
Detailed Table of Content:
- Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
- Executive Summary
- Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
- Key Insights
4.1. Prevalence of Asthma - by Key Regions - 2019
4.2. Pipeline Analysis
4.3. Key Industry Developments (Mergers, Acquisitions, and Partnerships, etc.)
4.4. Regulatory Scenario - by Key Regions
4.5. An Overview of Emerging Treatments for Asthma
4.6. An Overview of Guidelines for the Diagnosis and Management of Asthma (EPR-3)
4.7. Reimbursement Scenario - by Key Regions
- Global Asthma Treatment Market Analysis, Insights and Forecast, 2016-2027
5.1. Key Findings / Summary
5.2. Market Analysis, Insights and Forecast – By Treatment
5.2.1. Long-Term Control Medications
5.2.2. Quick-Relief Medications
5.3. Market Analysis, Insights and Forecast – By Route of Administration
5.3.1. Injectable
5.3.2. Oral
5.3.3. Inhaled
5.4. Market Analysis, Insights and Forecast – By Distribution Channel
5.4.1. Hospital Pharmacies
5.4.2. Retail Pharmacies & Drug Stores
5.4.3. Online Pharmacies
5.5. Market Analysis, Insights and Forecast – By Region
5.5.1. North America
5.5.2. Europe
5.5.3. Asia pacific
5.5.4. Latin America
5.5.5. Middle East & Africa
- North America Asthma Treatment Market Analysis, Insights and Forecast, 2016-2027
6.1. Key Findings / Summary
6.2. Market Analysis – By Treatment
6.2.1. Long-Term Control Medications
6.2.2. Quick-Relief Medications
6.3. Market Analysis – By Route of Administration
6.3.1. Injectable
6.3.2. Oral
6.3.3. Inhaled
6.4. Market Analysis – By Distribution Channel
6.4.1. Hospital Pharmacies
6.4.2. Retail Pharmacies & Drug Stores
6.4.3. Online Pharmacies
6.5. Market Analysis – By Country
6.5.1. U.S.
6.5.2. Canada
- Europe Asthma Treatment Market Analysis, Insights and Forecast, 2016-2027
7.1. Key Findings / Summary
7.2. Market Analysis – By Treatment
7.2.1. Long-Term Control Medications
7.2.2. Quick-Relief Medications
7.3. Market Analysis – By Route of Administration
7.3.1. Injectable
7.3.2. Oral
7.3.3. Inhaled
7.4. Market Analysis – By Distribution Channel
7.4.1. Hospital Pharmacies
7.4.2. Retail Pharmacies & Drug Stores
7.4.3. Online Pharmacies
7.5. Market Analysis – By Country/ sub-region
7.5.1. U.K.
7.5.2. Germany
7.5.3. France
7.5.4. Spain
7.5.5. Italy
7.5.6. Scandinavia
7.5.7. Rest of Europe
- Asia pacific Asthma Treatment Market Analysis, Insights and Forecast, 2016-2027
8.1. Key Findings / Summary
8.2. Market Analysis – By Treatment
8.2.1. Long-Term Control Medications
8.2.2. Quick-Relief Medications
8.3. Market Analysis – By Route of Administration
8.3.1. Injectable
8.3.2. Oral
8.3.3. Inhaled
8.4. Market Analysis – By Distribution Channel
8.4.1. Hospital Pharmacies
8.4.2. Retail Pharmacies & Drug Stores
8.4.3. Online Pharmacies
8.5. Market Analysis – By Country/ sub-region
8.5.1. Japan
8.5.2. China
8.5.3. India
8.5.4. Australia
8.5.5. Southeast Asia
8.5.6. Rest of Asia Pacific
- Latin America Asthma Treatment Market Analysis, Insights and Forecast, 2016-2027
9.1. Key Findings / Summary
9.2. Market Analysis – By Treatment
9.2.1. Long-Term Control Medications
9.2.2. Quick-Relief Medications
9.3. Market Analysis – By Route of Administration
9.3.1. Injectable
9.3.2. Oral
9.3.3. Inhaled
9.4. Market Analysis – By Distribution Channel
9.4.1. Hospital Pharmacies
9.4.2. Retail Pharmacies & Drug Stores
9.4.3. Online Pharmacies
9.5. Market Analysis – By Country/ sub-region
9.5.1. Brazil
9.5.2. Mexico
9.5.3. Rest of Latin America
- Middle East & Africa Asthma Treatment Market Analysis, Insights and Forecast, 2016-2027
10.1.Key Findings / Summary
10.2.Market Analysis – By Treatment
10.2.1. Long-Term Control Medications
10.2.2. Quick-Relief Medications
10.3.Market Analysis – By Route of Administration
10.3.1. Injectable
10.3.2. Oral
10.3.3. Inhaled
10.4.Market Analysis – By Distribution Channel
10.4.1. Hospital Pharmacies
10.4.2. Retail Pharmacies & Drug Stores
10.4.3. Online Pharmacies
10.5.Market Analysis – By Country/ sub-region
10.5.1. GCC Countries
10.5.2. South Africa
10.5.3. Rest of Middle East & Africa
Continued...